Ibrahimov, F. et al. 2026. Cardiopulmonary Effects of Combined β1-Selective Blockers, Ivabradine, and β2-Agonists in Ischemic Heart Disease with Chronic Obstructive Pulmonary Disease. Journal of Heart Disease and Therapy. 3, 01 (Mar. 2026), 24–26. DOI:https://doi.org/10.71295/JHDT.2026.03.1.06.